Immuto Scientific的动态

You may remember our LKD post where we introduced you to?BioPALS, our?innovative, lean, and versatile?HIT identification?platform combining AI-powered virtual screening with cutting-edge biophysical technologies. Today, we're excited to offer you the opportunity to?download our BioPALS poster below ??? showcasing how our platform is set to revolutionize HIT Identification. If you are looking to start your discovery project for less today,?book an appointment?with Dr Tom Pesnot (Drug Discovery Services Director) and Lorraine Hendry (Director of Business Development) today https://lnkd.in/dUUuFAeu

The transfer of research results into real life is one of the key points of the Brnoregion Microscopy mission. And so the discussion at this morning's commercialisation workshop is very lively. Do you have an idea for commercialisation or like to get involved? Let us know! ??

How should we compare machine learning methods in drug discovery? In the first working paper from the Small Molecule Steering Committee at Polaris, we introduced guidelines for method comparison to help ensure fair, replicable, and rigorous evaluations in ML-driven drug discovery. Now, we’re taking the conversation LIVE! ???When: Dec 5th from 11 - 12 PM ET ???Where: https://lnkd.in/gs2SVrPC Join host Jonathan Hsu from Valence Labs / Recursion and first author Jeremy Ash from Johnson & Johnson Innovative Medicine for an interactive session where we’ll: ? Explore the key points from the paper ? Discuss its implications for the field ? Open the floor to your questions and ideas Let’s work together to redefine how method comparison is done!

How should we compare machine learning methods in drug discovery? In the first working paper from the Small Molecule Steering Committee at Polaris, we introduced guidelines for method comparison to help ensure fair, replicable, and rigorous evaluations in ML-driven drug discovery. Now, we’re taking the conversation LIVE! ???When: Dec 5th from 11 - 12 PM ET ???Where: https://lnkd.in/gs2SVrPC Join host Jonathan Hsu from Valence Labs / Recursion and first author Jeremy Ash from Johnson & Johnson Innovative Medicine for an interactive session where we’ll: ? Explore the key points from the paper ? Discuss its implications for the field ? Open the floor to your questions and ideas Let’s work together to redefine how method comparison is done!

?? LIVE?? Join Dr. Alex J Krotulski, NPS discovery program manager, The Center for Forensic Science Research & Education, as he dives deep into uncovering emerging drugs with NPS discovery with host Pierre Negri. Don't miss this insightful discussion! ??? Episode 2: Uncover emerging drugs with NPS discovery Watch now: https://sciex.li/p61dty

GO Virginia Region 2 project GMP CLEAN will address the need for cleanroom space by surveying region and statewide needs. The project will implement a pilot cleanroom space at the Fralin Biomedical Research Institute at VTC (FBRI) and will see use from three local startup companies to manufacture biomedicines: The Tiny Cargo Company, Qentoros, and Acomhal Research, Inc.. Learn more from Spencer Marsh, senior research scientist for FBRI!?